Skip to main content
Physiological Reports logoLink to Physiological Reports
. 2021 Aug 17;9(16):e14957. doi: 10.14814/phy2.14957

In creatinine kinetics, the glomerular filtration rate always moves the serum creatinine in the opposite direction

Sheldon Chen 1,, Robert Chiaramonte 2
PMCID: PMC8371355  PMID: 34405576

Abstract

Introduction

When the serum [creatinine] is changing, creatinine kinetics can still gauge the kidney function, and knowing the kinetic glomerular filtration rate (GFR) helps doctors take care of patients with renal failure. We wondered how the serum [creatinine] would respond if the kinetic GFR were tweaked. In every scenario, if the kinetic GFR decreased, the [creatinine] would increase, and vice versa. This opposing relationship was hypothesized to be universal.

Methods

Serum [creatinine] and kinetic GFR, along with other parameters, are described by a differential equation. We differentiated [creatinine] with respect to kinetic GFR to test if the two variables would change oppositely of each other, throughout the gamut of all allowable clinical values. To remove the discontinuities in the derivative, limits were solved.

Results

The derivative and its limits were comprehensively analyzed and proved to have a sign that is always negative, meaning that [creatinine] and kinetic GFR must indeed move in opposite directions. The derivative is bigger in absolute value at the higher end of the [creatinine] scale, where a small drop in the kinetic GFR can cause the [creatinine] to shoot upward, making acute kidney injury similar to chronic kidney disease in that regard.

Conclusions

All else being equal, a change in the kinetic GFR obligates the [creatinine] to change in the opposite direction. This does not negate the fact that an increasing [creatinine] can be compatible with a rising kinetic GFR, due to differences in how the time variable is treated.

Keywords: creatinine clearance, differential equation, kinetic GFR, partial derivative


Changes in creatinine are tightly coupled to changes in kinetic GFR. From an established differential equation, the derivative of creatinine with respect to kinetic GFR was calculated. With it, we mathematically prove that all else being equal, if the kinetic GFR goes down, then the creatinine must go up, and vice versa. The two always move in opposite directions.

graphic file with name PHY2-9-e14957-g002.jpg

1. INTRODUCTION

Throughout the world, the serum creatinine is the most common measure for doctors to assess a patient's kidney function. Instinctively, they know that when the creatinine increases, the kidney function decreases (with exceptions), and vice versa. How quickly the creatinine is rising also has some bearing upon the severity of kidney function loss (Chiou & Hsu, 1975; Jelliffe, 2002; Mellas, 2016; Moran & Myers, 1985; Yashiro et al., 2012). Generally, the steeper the rise, the greater the impairment in the renal clearance. This creatinine slope is usually estimated from a graph generated by the electronic health record, and translating slope into kidney function is a decidedly qualitative art. Creatinine slope analysis became more quantitative when the science of creatinine kinetics was applied, a technique that has been called the kinetic glomerular filtration rate (GFR) (Chen, 2013, 2018a, 2018b; Chen & Chiaramonte, 2019). Now, the creatinine trajectory with all its slopes can be decoded into a kinetic GFR format that shows how the kidney function is evolving. Insight into the underlying kidney function by using the kinetic GFR has improved the diagnosis and treatment of patients who suffer from an acute kidney injury (AKI) (Bairy, 2020; Bairy et al., 2018; Dash et al., 2020; Dewitte et al., 2015; Endre et al., 2016; Khayat et al., 2019; Kwong et al., 2019; Latha et al., 2020; O'Sullivan & Doyle, 2017; Pianta et al., 2015; Yoshida et al., 2019). With creatinine kinetics being modeled mathematically, a question that naturally arises is how much does the [creatinine] change in response to a change in kinetic GFR? The answer can be found using derivatives.

1.1. Kinetic GFR equation

Changes in the serum creatinine follow passively from changes in the GFR, so like cause and effect, the change in GFR precedes and actively drives the change in creatinine. The creatinine serves mostly as a surrogate to calculate the GFR. The [creatinine] is relatable to the GFR by a differential equation (Chen, 2018a; Chen & Chiaramonte, 2019). The rate of change in the creatinine amount is a function of the rate of creatinine coming in minus the rate of creatinine going out of its volume of distribution, which is total body water (TBW) (Chow, 1985; Edwards, 1959; Jones & Burnett, 1974; Pickering et al., 2013). Most of the gain comes from creatinine being generated by the muscles, the mass of which remains more or less the same in the short term, so that the rate of creatinine addition is usually taken to be a constant: Gen. Most of the creatinine loss occurs via the kidneys, so that the rate of creatinine excretion is GFRK ·[Cr]t, a product of the kinetic GFR and the serum [creatinine] at an instant in time. On the left side of the differential equation, the instantaneous rate of change in creatinine amount is ddtCrt·Vt, where [Cr]t is the serum [creatinine] at a given point in time, as before, and Vt is the volume of distribution at the same point in time. Further, Vt is allowed to vary at a steady rate to mimic the clinical reality that patients have many fluid inputs and outputs (I's/O's), like intravenous (IV) fluids and urine output. The net balance of the I's/O's divided by the time period over which they occur can be modeled as a constant rate of change in the creatinine's volume of distribution: ΔVΔt. Thus, volume as a function of time is Vt=V0+ΔVΔtt, where V 0 is the initial volume at a time zero for each clinical time interval. The full differential equation can be written as:

ddtCrt·Vt=GenGFRK·Crt. (1)

This first‐order linear differential equation's solution, as previously published, is:

Crt=Cr0+1V0V0+ΔVΔtt1+GFRKΔVΔtTime evolution·GenGFRK+ΔVΔtCr0Crspread. (2)

where Cr0 is the initial serum [creatinine] for each clinical time interval (Chen, 2018a; Chen & Chiaramonte, 2019). That is to say, the serum [creatinine] at a given time is equal to the initial [creatinine] plus a time‐evolved portion of the spread between the initial [creatinine] and the [creatinine] reached at a new steady state if the kinetic GFR and volume change rate remained at those levels.

To show how the [creatinine] trajectory is shaped by the kinetic GFR and other variables, we can graph the [Cr]t for a typical occurrence of AKI. Let us say that a patient with a baseline [creatinine] of 1.0 mg/dL develops acute tubular injury, and his GFR drops to 10 mL/min and stays there. He receives copious amounts of IV fluids in an attempt to reverse the renal failure, so that the net of the I's/O's is +6 L in 24 h, or ΔVΔt=0.25L/h. The creatinine generation rate is found by multiplying the baseline [creatinine] by its corresponding steady‐state GFR: Gen=1mg/dL×90mL/min. His initial volume of distribution, V0, is taken to be TBW (Bjornsson, 1979), and a typical value is 42 L. The drop in GFR to a constant (average) value of 10 mL/min perturbs the steady state, so [creatinine] will change. We graphed the serum [creatinine] y versus kinetic GFR x to directly visualize the relationship between the two. If we imagine the tangent to this curve, it appears that the slope is consistently negative (Figure 1). We hypothesize that the tangential slope of [creatinine] versus kinetic GFR will always be negative.

FIGURE 1.

FIGURE 1

Visualizing the accuracy of CrtGFRK as written in Equation (3). The kinetic GFR Equation (2) is graphed as GFRK on the x‐axis and Crt on the y‐axis. The red curve slopes downward from left to right, and all of its tangent slopes appear to be negative. Two such tangent slopes at GFRK=10 (orange dot) and GFRK=90 (green dot) were calculated by the CrtGFRK equation. The derivative slopes are negative, as expected, and the calculated lines (black dash for GFRK=10 and purple dash for GFRK=90) do appear to be tangents.

2. MATERIALS AND METHODS

2.1. Derivative of [creatinine] with respect to kinetic GFR

From kinetic GFR Equation (2), we can differentiate the serum [creatinine], Crt, with respect to the kinetic GFR, GFRK, to find the instantaneous relationship between the two, assuming that all of the other variables are constant. This derivative CrtGFRK allows us to calculate the slope of the tangent to the curve of Crt versus GFRK. In Equation (2), the derivative of 1V0V0+ΔVΔtt1+GFRKΔVΔt is V0V0+ΔVΔtt1+GFRKΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtt. Next, the derivative of GenGFRK+ΔVΔtCr0 is GenGFRK+ΔVΔt2. Putting it all together and using the product rule on Equation (2), we see that CrtGFRK is:

CrtGFRK=V0V0+ΔVΔtt1+GFRKΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtta×GenGFRK+ΔVΔtCr0b+1V0V0+ΔVΔtt1+GFRKΔVΔta·GenGFRK+ΔVΔt2b. (3)

2.2. Limits

The derivative in Equation (3) has three special cases that threaten a division by zero: (1) ΔVΔt=0, (2) GFRK=ΔVΔt, and (3) GFRK=ΔVΔt=0, which itself is a special case of (2). Each of these cases can be resolved by using limits. See Appendix for derivation details.

Case 1: ΔVΔt=0.

Of the three cases, this is the most important clinically, as a stable volume is common or at least is assumed when information on I's/O's is unavailable.

limΔVΔt0CrtGFRK=eGFRK·tV0·tV0·GenGFRKCr01eGFRK·tV0·GenGFRK2. (4)

Case 2: GFRK=ΔVΔt.

limGFRKΔVΔtCrtGFRK=1ΔVΔt·lnV0V0+ΔVΔtt·Gen2·ΔVΔt·lnV0V0+ΔVΔttCr0. (5)

Case 3: GFRK=ΔVΔt=0.

limGFRK,ΔVΔt0,0CrtGFRK=tV0·Gen·t2·V0+Cr0. (6)

3. RESULTS

3.1. Hypothesis plausibility

To see if our intuition is on the right track that CrtGFRK is always negative, we graphed CrtGFRK y versus GFRK x (Figure 2). For the remaining variables, we kept them constant at clinically plausible values and tried various permutations, such as a low V0, standard time, large ΔVΔt (both ±), high Cr0, and small Gen, to see if we could turn CrtGFRK positive. No matter what combination was tried, CrtGFRK was always negative, i.e., below the x‐axis.

FIGURE 2.

FIGURE 2

The partial derivative CrtGFRK in Equation (3) is graphed against GFRK as the independent variable. The red curve retains the miscellaneous clinical values as chosen in Figure 1. All of its y‐values CrtGFRK are negative, consistent with the hypothesis that changes in [creatinine] and kinetic GFR always move in opposite directions if all of the other variables are kept constant. The blue curve uses a more extreme but still allowable set of clinical values like Cr0=9.0mg/dL, V0=30L, ΔVΔt=0.25L/h, Gen=40mg/dL·mL/min, while keeping t=24h. Even so, the blue curve's y‐values CrtGFRK are persistently negative.

3.2. Rules for the proof

All of the variables have constraints on their values as imposed by clinical reality. The rules are:

  • A.

    Creatinine must be positive: Crt>0 and Cr0>0.

  • B.

    Volume of distribution must be positive: V0>0 and V0+ΔVΔtt>0.

  • C.

    Kinetic GFR is traditionally non‐negative: GFRK0.

  • D.

    The creatinine generation rate must be positive: Gen>0.

  • E.

    Volume change rate can be positive or negative, but it cannot be so negative in magnitude that a patient would lose all of the volume of distribution in an allotted time ΔVΔt>V0t. In theory, a positive volume change rate has no upper limit on magnitude ΔVΔt<+.

3.3. Proof of the hypothesis

The derivative, rearranged to emphasize the leading negative sign, is hypothesized to always be negative for clinically realistic values, that is, the expression in the curly brace must be positive.

CrtGFRK=V0V0+ΔVΔtt1+GFRKΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtt·GenGFRK+ΔVΔtCr0+1V0V0+ΔVΔtt1+GFRKΔVΔt·GenGFRK+ΔVΔt2.

The general strategy will be a proof by contradiction. We test whether the expression within the curly brace can be negative and prove that it cannot, in all six of the scenarios that are possible. Thus, the partial derivative CrtGFRK is always negative (except when it is zero at t=0, which is a trivial case). Due to its length, the complete proof is presented in the Appendix.

3.4. Where is the derivative bigger?

An observation familiar to nephrologists is that a small change at the low end of the [creatinine] scale represents a big change in GFR, whereas a big change at the high end of the [creatinine] scale represents a small change in GFR. A typical anecdote is that an increase in the [creatinine] from 1.0 to 2.0 mg/dL is akin to a 50% decrease in the GFR. But the same absolute increase in the [creatinine] from 9.0 to 10.0 mg/dL is only a 10% drop in the GFR. The statements assume that each [creatinine] was more or less in a steady state, which models a slowly progressive chronic kidney disease (CKD). In CKD, the creatinine excretion rate is nearly equal to but is slightly less than the creatinine production rate, which is why the serum [creatinine] slowly increases over time. Since the creatinine production rate is relatively constant if the patient's muscle mass remains stable, then the clearance expression UCr×VCreatinineexcretion ratePCrPlasmacreatinine is more or less a constant divided by a [creatinine] that varies, i.e., a reciprocal function. On a graph of Cr versus GFR in CKD, at the low end of the Cr scale, a big loss of GFR (x‐axis) is needed to raise the Cr (y‐axis) even a tiny bit. That makes the ΔCrtinyΔGFRbig slope small, and negative, demonstrated in Figure 3. But at the high end of the Cr scale, just a tiny loss of GFR leverages a big rise in Cr, making ΔCrbigΔGFRtiny large and, again, negative (Figure 3). Thus, a reciprocal function's very nature explains the anecdote observed in CKD.

FIGURE 3.

FIGURE 3

Analogous to CrtGFRK, the ΔCrΔGFR slopes in chronic kidney disease are also negative. In CKD, the [creatinine] (y‐axis) is simply the Gen in this case90mg/dL·mL/min divided by the GFR (x‐axis), a reciprocal function as shown by the red curve. At the low end of the [creatinine] scale, e.g., green dot Cr=1mg/dL, the ΔCrΔGFR slope is small in magnitude (−1/90, green dash line is tangent). At the high end of the [creatinine] scale, e.g., blue dot Cr=9mg/dL, the ΔCrΔGFR slope is much larger in magnitude (−0.9, blue dash line is tangent).

Do the slope lessons of CKD carry over into AKI? That is, does the AKI analog of ΔCrΔGFR, i.e., CrtGFRK, follow the same pattern as before: low Cr0 ⇒ smaller CrtGFRK and high Cr0 ⇒ larger CrtGFRK (in magnitude)? Try a low initial Cr like 1.0 mg/dL. In steady state, that may correspond to a GFR of 90 mL/min if the creatinine generation rate were 90 mg/dL·mL/min. Let the kinetic GFR change from 90 mL/min and graph its effect on the Crt, using Equation (2). For the other parameters of AKI, we kept t=24h and V0=42L and ΔVΔt=0.25L/h. As seen in Figure 4, the tangent to the curve at GFRK=90mL/min has a CrtGFRK slope that is shallow 0.009722536mg/dL per mL/min. Now, try a high initial Cr like 9.0 mg/dL, which in steady state would correspond to a GFR of 10 mL/min. If we kept all other parameters the same, the tangent to this other curve at GFRK=10mL/min has a CrtGFRK slope that is steeper 0.217521268mg/dL per mL/min (Figure 4). This suggests that AKI recapitulates the behavior of CKD in terms of ΔCrΔGFR, albeit in a blunted way.

FIGURE 4.

FIGURE 4

To see if acute kidney injury might follow a similar pattern as chronic kidney disease, we visualized the steepness of the CrtGFRK slope when the starting [creatinine], Cr0, is low versus high. When the kinetic GFR Equation (2) is graphed as GFRK on the x‐axis and Crt on the y‐axis, the blue curve shows the relationship when Cr0=1.0 and the red curve shows the relationship when Cr0=9.0. For a fair comparison, the miscellaneous clinical values are kept the same between the two curves. At the low end of the [creatinine] scale, the tangent at Crt=0.96mg/dL (blue dot) has a slope of 0.0097mg/dL per mL/min (green dash line). At the high end of the [creatinine] scale, the tangent at Crt=8.03mg/dL (red dot) has a slope of 0.2175mg/dL per mL/min (black dash line). Qualitatively, the pattern appears to be that a low [creatinine] gives a smaller CrtGFRK and that a high [creatinine] gives a larger CrtGFRK, with all derivative signs being negative.

4. DISCUSSION

4.1. Clinical significance

The consistently negative value for CrtGFRK in the real world means that changes in kinetic GFR must always move in the opposite direction of changes in the serum [creatinine]. If the GFR goes up (even in the slightest), then more creatinine is excreted in that instant, and the [creatinine] must go down. Conversely, if the GFR goes down (even in the slightest), then less creatinine is excreted in that instant, and the [creatinine] must go up. Our proof of these assertions would affirm what most physicians intuitively sense about the relationship of GFR to the [creatinine]. Of course, this assumes that all of the other variables of creatinine kinetics like time and volume status remain constant, as is done when taking a partial derivative. All else being equal, a doctor can confidently know that the GFR can never change the [creatinine] in a parallel way. If at the 24‐h mark the [creatinine] were hypothetically greater than the actual—a positive ΔCr—, then the GFR would have to be lower—a negative ΔGFRK.

4.2. Conundrum

One important lesson from applying the kinetic GFR to patient care was that an increasing [creatinine] does not always imply a decreasing GFR. Most of the time though, the two move in opposite directions, and this mental shortcut is used daily on the wards. However, there is a gray zone where some instances of a rising [creatinine] actually indicate an improving GFR. Let us say during an episode of AKI that a low GFR rises slightly. That would increase the creatinine excretion, but if that excretion remained less than the creatinine production, then the net positive balance would obligate the serum [creatinine] to rise still. It is not until the GFR increases by a sufficient amount to make the creatinine excretion equal to the creatinine production that the serum [creatinine] finally stabilizes. Thus, there is a transient period in renal recovery when the GFR is increasing and the [creatinine] is too. But did we not just prove that GFR cannot move in the same direction as [creatinine]? The conundrum is resolved by realizing that time is different in the two scenarios. When GFR and [creatinine] are both increasing, they are doing so relative to time. For example, the [creatinine] may have risen from 1.0 initially to 1.9 and then to 2.0 mg/dL , but the latter two values occurred at the 24‐ and 48‐h marks. Concordantly, the kinetic GFR may have been calculated to climb from 40 to 44 mL/min , but these are also at the 24‐ and 48‐h marks. In contrast, the derivative CrtGFRK assumes that time is a constant. It forces us to compare GFR and [creatinine] to themselves, but both at the 24‐h mark, for example. With that time constancy, if [creatinine] were to increase marginally, then GFR would have to decrease marginally. Furthermore, we could quantify that change by calculating CrtGFRK's value. Allowing the [creatinine], kinetic GFR, and time to all vary simultaneously is beyond the scope of this work.

4.3. What if Gen is changing?

Differential Equation (1) is set up to assume that the creatinine generation rate, Gen, is constant. That may be true for the most part, but Gen could be decreased during a critical illness such as sepsis (Doi et al., 2009; Prowle et al., 2014). More than an academic exercise, this finding has important clinical ramifications. If less creatinine is being produced, then a [creatinine] trajectory may not rise as quickly, and that will mute the apparent severity of the GFR loss during AKI, for example. Or, it could make the [creatinine] trajectory fall more quickly during a renal recovery, making the GFR gain seem more robust than it really is. Accounting for a changing Gen can potentially improve the accuracy of the kinetic GFR calculations. Unfortunately, it is not known how Gen evolves over time in most of our critically ill patients. We can measure it to be decreased, but was the evolution a sudden drop, a gradual and linear drop, a logistic model drop, etc.? Until patient data are gathered, it may be acceptable to treat a changing Gen as a sudden drop to a new value that remains stably low throughout the critical illness. If the acute drop is completed within 24 h, then the kinetic GFR calculations are easy to adapt. Just use the reduced Gen, whatever it is estimated (or, better yet, measured) to be, in the kinetic spreadsheet at the onset of and for the duration of the critical illness. That said, a Gen drop that is linear, like how volume change is modeled, can be incorporated into our differential Equation (1) to yield a closed‐form solution. However, its utility is limited to one or two rounds of calculation, since Gen cannot descend into negative values.

4.4. Conclusion

Doctors need to estimate the kidney function in the non‐steady state to care for their patients who develop acute renal failure. The GFR affects most facets of diagnosis and therapy, and the most cost‐effective way to estimate GFR at the bedside is to use the kinetic GFR equation (Endre et al., 2016; Khayat et al., 2019). Its math contains a lot of relationships that are waiting to be discovered. How the GFR influences the serum [creatinine] is important to investigate, and we can now prove what doctors intuitively think. If the GFR were to decrease further, then the [creatinine] would have to go up even more, and vice versa. In other words, their changes always move in opposite directions, as signified by the perpetual negative sign of CrtGFRK. This does not contradict the paradoxical observations that an increase in serum [creatinine] can be compatible with a gain of kinetic GFR or that a decrease in [creatinine] can be compatible with a loss of kinetic GFR, because these changes are evolving over time. In contrast, time is fixed in the taking of the partial derivative.

4.5. Future work

Solving this derivative was just the beginning. We have since differentiated [creatinine] with respect to each of the other variables, and all of the other derivative pairs have been found via implicit differentiation. Likely, the most interesting derivative is CrtΔVΔt. If ΔVΔt is negative, the loss in volume concentrates the [creatinine] so that ΔCr is expected to be positive. Alternatively, if ΔVΔt is positive, the gain in volume dilutes the [creatinine] so that ΔCr is felt to be negative. Do these thought experiments prove that yet another derivative is always negative? The answer is no, and the potentially positive partial derivative of Crt with respect to ΔVΔt is (see Appendix):

CrtΔVΔt=V0V0+ΔVΔtt1+GFRKΔVΔt·GFRKΔVΔt2·lnV0V0+ΔVΔtt+1+GFRKΔVΔt·tV0+ΔVΔtt×GenGFRK+ΔVΔtCr0+1V0V0+ΔVΔtt1+GFRKΔVΔt·GenGFRK+ΔVΔt2.

ACKNOWLEDGMENTS

The graphs were generated at desmos.com/calculator. The authors have no conflicts of interest.

1. LIMITS

From the kinetic GFR equation (Equation (2) in the main text), the derivative of the serum [creatinine] Crt with respect to kinetic GFR GFRK is:

CrtGFRK=V0V0+ΔVΔtt1+GFRKΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtt·GenGFRK+ΔVΔtCr0+1V0V0+ΔVΔtt1+GFRKΔVΔt·GenGFRK+ΔVΔt2

The following three cases of a division by zero represent removable discontinuities that can be resolved by using limits.

Case 1: ΔVΔt=0.

We will solve the limit piecewise, proceeding through the various components of CrtGFRK.

To begin with, the exponential can be resolved as:

limΔVΔt0V0V0+ΔVΔtt1+GFRKΔVΔt=exp1+GFRKΔVΔt·lnV0V0+ΔVΔtt=exp1+GFRKΔVΔt·ln1+ΔVΔttV0+ΔVΔtt

The dominant term in the Taylor series for ln1+ΔVΔttV0+ΔVΔtt is ΔVΔttV0+ΔVΔtt+. Substitute this in:

exp1+GFRKΔVΔt·ΔVΔttV0+ΔVΔtt+=expΔVΔttV0+ΔVΔttGFRKΔVΔt·ΔVΔttV0+ΔVΔtt+=expΔVΔttV0+ΔVΔttGFRK·tV0+ΔVΔtt+

Now, let ΔVΔt go to zero, and the limit is seen to be:

limΔVΔt0V0V0+ΔVΔtt1+GFRKΔVΔt=expGFRK·tV0=eGFRK·tV0

Another part of the derivative affected by ΔVΔt=0 is 1ΔVΔt·lnV0V0+ΔVΔtt. Again, using the dominant term in the Taylor series for lnV0V0+ΔVΔtt, the limit becomes:

limΔVΔt01ΔVΔt·lnV0V0+ΔVΔtt=limΔVΔt01ΔVΔt·ΔVΔttV0+ΔVΔtt+=tV0

The rest of the derivative in the limit as ΔVΔt approaches zero is straightforward:

limΔVΔt0CrtGFRK=eGFRK·tV0·tV0·GenGFRKCr01eGFRK·tV0·GenGFRK2. (1)

Case 2: GFRK=ΔVΔt.

Although it is unlikely that the GFRK will equal the negative of the volume change rate, the limit is interesting to solve. Letting GFRK approach ΔVΔt is equivalent to stating that GFRK=ΔVΔt+h, and letting h approach zero. This substitution transforms CrtGFRK into:

CrtGFRK=V0V0+ΔVΔtt1+ΔVΔt+hΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtt·GenhCr0+1V0V0+ΔVΔtt1+ΔVΔt+hΔVΔt·Genh2
limh0CrtGFRK=V0V0+ΔVΔtthΔVΔte0- like·1ΔVΔt·lnV0V0+ΔVΔtt·GenhCr0+1V0V0+ΔVΔtthΔVΔte0- like·Genh2

We will solve the limit piecewise. First, find the Taylor expansion of the e0‐like expression:

limh0V0V0+ΔVΔtthΔVΔt=exphΔVΔt·lnV0V0+ΔVΔtt=1+hΔVΔt·lnV0V0+ΔVΔtt+h2ΔVΔt2·ln2V0V0+ΔVΔtt2!+

Substitute in the e0‐like Taylor expansion, and the first half of the limit becomes:

1+hΔVΔt·lnV0V0+ΔVΔtt+h22·ΔVΔt2·ln2V0V0+ΔVΔtt+·1ΔVΔt·lnV0V0+ΔVΔtt·GenhCr0
1ΔVΔt·lnV0V0+ΔVΔtt+hΔVΔt2·ln2V0V0+ΔVΔtt+h22·ΔVΔt3·ln3V0V0+ΔVΔtt+·GenhCr0
Genh·ΔVΔt·lnV0V0+ΔVΔttGenΔVΔt2·ln2V0V0+ΔVΔtth·Gen2·ΔVΔt3·ln3V0V0+ΔVΔtt+1ΔVΔt·lnV0V0+ΔVΔtt·Cr0+hΔVΔt2·ln2V0V0+ΔVΔtt·Cr0+h22·ΔVΔt3·ln3V0V0+ΔVΔtt·Cr0+

Substitute in the e0‐like Taylor expansion, and the second half of the limit becomes:

11+hΔVΔt·lnV0V0+ΔVΔtt+h22·ΔVΔt2·ln2V0V0+ΔVΔtt+h36·ΔVΔt3·ln3V0V0+ΔVΔtt+·Genh2
hΔVΔt·lnV0V0+ΔVΔtth22·ΔVΔt2·ln2V0V0+ΔVΔtth36·ΔVΔt3·ln3V0V0+ΔVΔtt+·Genh2
Genh·ΔVΔt·lnV0V0+ΔVΔtt+Gen2·ΔVΔt2·ln2V0V0+ΔVΔtt+h·Gen6·ΔVΔt3·ln3V0V0+ΔVΔtt+

Add the two halves of the limit together, and the problematic division by h0 is subtracted out:

Gen2·ΔVΔt2·ln2V0V0+ΔVΔtth·Gen3·ΔVΔt3·ln3V0V0+ΔVΔtt+1ΔVΔt·lnV0V0+ΔVΔtt·Cr0+hΔVΔt2·ln2V0V0+ΔVΔtt·Cr0+h22·ΔVΔt3·ln3V0V0+ΔVΔtt·Cr0+

Now, let h go to zero, and the limit is seen to be:

Gen2·ΔVΔt2·ln2V0V0+ΔVΔtt+1ΔVΔt·lnV0V0+ΔVΔtt·Cr0
limGFRKΔVΔtCrtGFRK=1ΔVΔt·lnV0V0+ΔVΔtt·Gen2·ΔVΔt·lnV0V0+ΔVΔttCr0. (2)

Case 3: GFRK=ΔVΔt=0.

In the even more unlikely event that the kinetic GFR and the volume change rate are both zero, the dual limit approaching zero can be solved by at least two ways:

(1). Equation (1) was the limit of CrtGFRK as ΔVΔt0. Now, take the limit as GFRK0:

limΔVΔt0CrtGFRK=eGFRK·tV0e0- like·tV0·GenGFRKCr01eGFRK·tV0e0- like·GenGFRK2

The Taylor expansion of the e0‐like term eGFRK·tV0 is 1+GFRK·tV0+GFRK·tV022!+ Substitute in:

limΔVΔt,GFRK0,0CrtGFRK=1GFRK·tV0+·tV0·GenGFRKCr0
11GFRK·tV0+GFRK2·t22·V02+·GenGFRK2
limΔVΔt,GFRK0,0CrtGFRK=t·GenV0·GFRKtV0·Cr0t2·GenV02+GFRK·t2V02·Cr0+
GFRK·tV0GFRK2·t22·V02+·GenGFRK2

The problematic division by GFRK0 is subtracted out:

limΔVΔt,GFRK0,0CrtGFRK=t·GenV0·GFRKtV0·Cr0Gen·t2V02+GFRK·t2V02·Cr0t·GenV0·GFRK+Gen·t22·V02+
limΔVΔt,GFRK0,0CrtGFRK=tV0·Cr0Gen·t22·V02+GFRK·t2V02·Cr0+

Now, let GFRK go to zero, and the limit is seen to be:

limΔVΔt,GFRK0,0CrtGFRK=tV0·Cr0Gen·t22·V02. (3)

(2). The same limit as above would be found if Equation (2) had let ΔVΔt approach zero:

limGFRKΔVΔtCrtGFRK=1ΔVΔt·lnV0V0+ΔVΔtt·Gen2·ΔVΔt·lnV0V0+ΔVΔttCr0

Substitute in the Taylor expansion of lnV0V0+ΔVΔtt as ΔVΔt0:

limGFRK,ΔVΔt0,0CrtGFRK=1ΔVΔt·ΔVΔttV0+ΔVΔtt·Gen2·ΔVΔt·ΔVΔttV0+ΔVΔttCr0
limGFRK,ΔVΔt0,0CrtGFRK=tV0+ΔVΔtt·Gen·t2·V0+ΔVΔttCr0

Now, let ΔVΔt go to zero, and the limit is seen to be:

limGFRK,ΔVΔt0,0CrtGFRK=tV0·Gen·t2·V0+Cr0. (4)

The dual limits in Equations (3) and (4) are mathematically equivalent, which also validates the precursor limits in Equation (1): stable volume ΔVΔt=0 and Equation (2): GFRK=ΔVΔt.

A fourth case of division by zero, V0+ΔVΔtt=0, has a limit that is undefined, which is just as well since patients cannot have a zero volume.

2. Proof that CrtGFRK is always negative

The derivative, rearranged to emphasize the leading negative sign, is hypothesized to always be negative for clinically realistic values, i.e., the expression in the curly brace must be positive.

CrtGFRK=V0V0+ΔVΔtt1+GFRKΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtt·GenGFRK+ΔVΔtCr0+1V0V0+ΔVΔtt1+GFRKΔVΔt·GenGFRK+ΔVΔt2

The general strategy will be a proof by contradiction. We test whether the expression within the curly brace can be negative and prove that it cannot, in all six of the scenarios that are possible.

The curly brace's sum breaks up into two groups:

3. GROUP 1:

V0V0+ΔVΔtt1+GFRKΔVΔtalways positive·1ΔVΔt·lnV0V0+ΔVΔttalways negative·GenGFRK+ΔVΔtCr0can be±; determines sign. (5)

The ratio of initial‐to‐final volume V0V0+ΔVΔtt must be positive, and a positive number raised to any real exponent is also positive.

In 1ΔVΔt·lnV0V0+ΔVΔtt, a negative ΔVΔt makes the fraction V0V0+ΔVΔtt>1, which makes its logarithm positive. Here, the product 1ΔVΔt·lnV0V0+ΔVΔtt is negative. On the other hand, a positive ΔVΔt makes the fraction V0V0+ΔVΔtt<1, which makes its logarithm negative. Either way, the product 1ΔVΔt·lnV0V0+ΔVΔtt is negative. (A zero ΔVΔt is handled separately.)

The GenGFRK+ΔVΔtCr0 represents the spread between the initial [creatinine] and the eventual steady‐state [creatinine]. If the [creatinine] is rising, the spread is positive. If the [creatinine] is falling, the spread is negative. Since GenGFRK+ΔVΔtCr0 can take on either sign, it determines the overall sign of the three‐term product in Group 1.

4. GROUP 2:

GenGFRK+ΔVΔt2always positive·1V0V0+ΔVΔtt1+GFRKΔVΔtcan be±; determines sign. (6)

In GenGFRK+ΔVΔt2, Gen is positive, and the square GFRK+ΔVΔt2 is positive in the real numbers.

In 1V0V0+ΔVΔtt1+GFRKΔVΔt, a positive ΔVΔt makes 0<V0V0+ΔVΔtt<1 and the exponent 1+GFRKΔVΔt>0. A base between zero and one raised to a positive exponent has a range between zero and one as well. Subsequently, 1V0V0+ΔVΔtt1+GFRKΔVΔt is positive.

However, a negative ΔVΔt makes V0V0+ΔVΔtt>1, and raising this to any positive or negative exponent 1+GFRKΔVΔt makes it positive and potentially greater than one. Subsequently, 1V0V0+ΔVΔtt1+GFRKΔVΔt can be either positive or negative, thus determining the overall sign of Group 2.

Broadly, there are 3 ways to falsify the hypothesis by having a curly brace value that is negative. Referring to expression (5)—Group 1—and expression (6)—Group 2, the ways are:

1. Positive or zero GenGFRK+ΔVΔtCr0 in Group 1 and Negative 1V0V0+ΔVΔtt1+GFRKΔVΔt in Group 2.

2. Positive GenGFRK+ΔVΔtCr0 and Positive 1V0V0+ΔVΔtt1+GFRKΔVΔt and Group1>Group23rd condition.

3. Negative GenGFRK+ΔVΔtCr0 and Negative 1V0V0+ΔVΔtt1+GFRKΔVΔt and Group1<Group23rd condition.

Test Each Falsifying Way:

1. If GenGFRK+ΔVΔtCr00, then GFRK<ΔVΔtGFRK+GenCr0. (Note: ΔVΔt=0 is covered separately.)

Substitute these ΔVΔt’s into the exponent 1+GFRKΔVΔt to get the two bounds: zero on one end and GenCr0ΔVΔt, after simplifying and back‐substituting, on the other end.

Analyze the more interesting bound on the exponent: 1V0V0+ΔVΔttGenCr0ΔVΔt:

i. If ΔVΔt is negative, then 1V0V0+ΔVΔtt>1GenCr0ΔVΔtNegative and the whole expression is positive, specifically that 0<1V0V0+ΔVΔttGenCr0ΔVΔt<1.

ii. If ΔVΔt is positive, then 1V0V0+ΔVΔtt<1GenCr0ΔVΔtPositive and the whole expression is positive, specifically that 0<1V0V0+ΔVΔttGenCr0ΔVΔt<1 again.

In both cases, the 1V0V0+ΔVΔtt1+GFRKΔVΔt was positive, but it needed to be negative. Therefore, Way #1 does not falsify the hypothesis.

2. As learned in 1, if GenGFRK+ΔVΔtCr0>0, then 1V0V0+ΔVΔtt1+GFRKΔVΔt has to be positive. Together, they satisfy two out of the three conditions in 2. The 3rd condition, then, is key.

Requiring Group 1>Group 2 is equivalent to asking if

V0V0+ΔVΔtt1+GFRKΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtt·GenGFRK+ΔVΔtCr0Group 1 negative+GenGFRK+ΔVΔt2·1V0V0+ΔVΔtt1+GFRKΔVΔtGroup 2 positive<0

Given that GenGFRK+ΔVΔt>Cr0, let GenGFRK+ΔVΔt=aCr0. Then a>1.

Also, since GenGFRK+ΔVΔt is greater than a positive value of Cr0, then GFRK+ΔVΔt>0.

In Group 2, GenGFRK+ΔVΔt2=GenGFRK+ΔVΔt=aCr0·1GFRK+ΔVΔt=aCr0GFRK+ΔVΔt. Substitute these in:

V0V0+ΔVΔtt1+GFRKΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtt·aCr0Cr0+aCr0GFRK+ΔVΔt·1V0V0+ΔVΔtt1+GFRKΔVΔt<0
V0V0+ΔVΔtt1+GFRKΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtt·a1+aGFRK+ΔVΔtPositive·1V0V0+ΔVΔtt1+GFRKΔVΔt<0
V0V0+ΔVΔtt1+GFRKΔVΔt·GFRK+ΔVΔtΔVΔt·lnV0V0+ΔVΔtt·a1a+1V0V0+ΔVΔtt1+GFRKΔVΔt<0
e1+GFRKΔVΔt·lnV0V0+ΔVΔtt·1+GFRKΔVΔt·lnV0V0+ΔVΔtt·a1a+1e1+GFRKΔVΔt·lnV0V0+ΔVΔtt<0

Let 1+GFRKΔVΔt·lnV0V0+ΔVΔtt=x. Because GFRK+ΔVΔt>0, we restrict ΔVΔt>GFRK. If ΔVΔt is negative, then GFRKΔVΔt<1 and 1+GFRKΔVΔt is negative. If ΔVΔt is positive, then 1+GFRKΔVΔt is positive. Whichever sign 1+GFRKΔVΔt has, the lnV0V0+ΔVΔtt must take on the opposite sign, making 1+GFRKΔVΔtNeg/Pos·lnV0V0+ΔVΔttPos/Neg negative either way, so x has to be positive x>0.

(Note: ΔVΔt=GFRK and ΔVΔt=GFRK=0 are covered separately.)

Substitute in: ex·x·a1a+1ex<0.

Multiply both sides by ex: x·a1a+ex1<0.

Let fx=exa1a·x1. Is this function always negative when x>0

Differentiate the function: fx=exa1a.

Because x>0, then ex>1. In contrast, because a>1, then 0<a1a<1.

The subtraction yields an fx that is positive, meaning that fx is increasing on x>0.

As x approaches zero from the right, fx must have a minimum of limx0+exa1a·x1=0.

Thus, fx is always positive, but that contradicts fx=exa1a·x1 needing to be negative, so Way #2 does not falsify the hypothesis.

3. If GenGFRK+ΔVΔtCr0<0, then ΔVΔt<GFRKor0 OR GFRK+GenCr0+<ΔVΔt.

i. If ΔVΔt<GFRK, then 1V0V0+ΔVΔtt>11+GFRKΔVΔtPositive is negative, as required in 3. OR:

ii. If GFRK+GenCr0<ΔVΔt<0, then 1V0V0+ΔVΔtt>11+GFRKΔVΔtNegative is positive.

(Note: ΔVΔt=0 is covered separately.)

iii. If 0GFRK+GenCr0<ΔVΔt, then 1V0V0+ΔVΔtt<11+GFRKΔVΔtPositive is positive.

The latter two cases violate the 2nd condition that 1V0V0+ΔVΔtt1+GFRKΔVΔt be negative, so only the first case of ΔVΔt<GFRK needs to be considered.

Once again, the 3rd condition is key, but this time Group 1<Group 2.

Requiring Group 1<Group 2 is equivalent to asking if

V0V0+ΔVΔtt1+GFRKΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtt·GenGFRK+ΔVΔtCr0Group 1 positive+GenGFRK+ΔVΔt2·1V0V0+ΔVΔtt1+GFRKΔVΔtGroup 2 negative<0

So if GenGFRK+ΔVΔt<Cr0, let GenGFRK+ΔVΔt=bCr0. Then b<1.

Additionally, because of ΔVΔt<GFRK above, GenGFRK+ΔVΔt must be negative. So, really, b<0.

In Group 2, GenGFRK+ΔVΔt2=GenGFRK+ΔVΔt=bCr0·1GFRK+ΔVΔt=bCr0GFRK+ΔVΔt. Substitute these in:

V0V0+ΔVΔtt1+GFRKΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtt·bCr0Cr0+bCr0GFRK+ΔVΔt·1V0V0+ΔVΔtt1+GFRKΔVΔt<0
V0V0+ΔVΔtt1+GFRKΔVΔt·1ΔVΔt·lnV0V0+ΔVΔtt·b1+bGFRK+ΔVΔtPositive·1V0V0+ΔVΔtt1+GFRKΔVΔt<0
V0V0+ΔVΔtt1+GFRKΔVΔt·GFRK+ΔVΔtΔVΔt·lnV0V0+ΔVΔtt·b1b+1V0V0+ΔVΔtt1+GFRKΔVΔt<0
e1+GFRKΔVΔt·lnV0V0+ΔVΔtt·1+GFRKΔVΔt·lnV0V0+ΔVΔtt·b1b+1e1+GFRKΔVΔt·lnV0V0+ΔVΔtt<0

Let 1+GFRKΔVΔt·lnV0V0+ΔVΔtt=x. Here, ΔVΔt<GFRK, which makes 1+GFRKΔVΔtPositive·lnV0V0+ΔVΔttPositive always positive, so x>0.

Substitute in:ex·x·b1b+1ex<0.

Multiply both sides by ex: x·b1b+ex1<0.

Let fx=b1b·x+ex1. Is this function always negative when x>0

Differentiate the function: fx=b1bex.

Because b<0, then b1b>1. In contrast, because x>0, then 0<ex<1.

The subtraction yields an fx that is positive, meaning that fx is increasing on x>0.

As x approaches zero from the right, fx must have a minimum of limx0+b1b·x+ex1=0.

Thus, fx is always positive, but that contradicts fx=b1b·x+ex1 needing to be negative, so Way #3 does not falsify the hypothesis.

Limit cases:

4. If ΔVΔt=0, then the limit solution is given by Equation (1), shown below:

limΔVΔt0CrtGFRK=eGFRK·tV0·tV0·GenGFRKCr01eGFRK·tV0·GenGFRK2

Disregarding the trivial case of t=0 that makes CrtGFRK=0, term by term, the signs have to be

limΔVΔt0CrtGFRK=eGFRK·tV0Positive·tV0+·GenGFRKCr0can be±or 01eGFRK·tV0Positive·GenGFRK2Positive

(Note: ΔVΔt=GFRK=0 is analyzed later.)

i. If GenGFRKCr00, then the derivative limit is negative, which supports the hypothesis.

ii. If GenGFRKCr0>0, then the derivative limit is potentially positive. Clinically, is it possible that eGFRK·tV0·tV0·GenGFRKCr01eGFRK·tV0·GenGFRK2>0

Since GenGFRK>Cr0, let GenGFRK=cCr0. Then c>1.

Further, GenGFRK2=GenGFRK=cCr0·1GFRK=cCr0GFRK. Substitute these in:

eGFRK·tV0·tV0·cCr0Cr01eGFRK·tV0·cCr0GFRK>0
eGFRK·tV0·tV0·c11eGFRK·tV0·cGFRKPositive>0
eGFRK·tV0·GFRK·tV0·c1c1+eGFRK·tV0>0

Let GFRK·tV0=x. By inspection, x>0 (not considering GFRK=0 yet or t=0 at all).

Substitute in:

ex·x·c1c1+ex>0

Multiply both sides by ex: x·c1cex+1>0.

Let fx=c1c·xex+1. Is this function always positive when x>0

Differentiate the function: fx=c1cex.

Because c>1, then 0<c1c<1. In contrast, because x>0, then ex>1.

The subtraction yields an fx that is negative, meaning that fx is decreasing on x>0.

As x approaches zero from the right, fx must have a maximum of limx0+c1c·xex+1=0.

Thus, fx is always negative, but that contradicts fx=c1c·xex+1 needing to be positive, so the overall derivative's limit as ΔVΔt0 must be negative.

5. If GFRK=ΔVΔt, then the limit solution is given by Equation (2), shown below:

limGFRKΔVΔtCrtGFRK=1ΔVΔt·lnV0V0+ΔVΔtt·Gen2·ΔVΔt·lnV0V0+ΔVΔttCr0

Clinically, GFRK is positive, forcing ΔVΔt to be negative. (Note: GFRK=ΔVΔt=0 is analyzed next.) Then, term by term, the signs have to be:

1ΔVΔt·lnV0V0+ΔVΔttNegative·Gen2·ΔVΔt·lnV0V0+ΔVΔttNegativeCr0Positive.

The negative sign out in front makes the entire derivative limit negative, which supports the hypothesis that CrtGFRK is always negative (disregarding the trivial case of t=0).

6. If GFRK=ΔVΔt=0, then the limit solution is given by Equation (4), shown below:

limGFRK,ΔVΔt0,0CrtGFRK=tV0·Gen·t2·V0+Cr0.

Disregarding the trivial case of t=0, term by term, the signs have to be tV0+·Gen·t2·V0Positive+Cr0Positive.

The negative sign out in front makes the entire derivative limit negative, which supports the hypothesis that CrtGFRK is always negative.

Conclusion: All six ways that the partial derivative could be positive were falsified. Therefore, the derivative CrtGFRK is always negative (except when it is zero at t=0).

Lastly, the partial derivative of Crt with respect to ΔVΔt is derived as follows:

In Equation (2) of the main text, the derivative of 1V0V0+ΔVΔtt1+GFRKΔVΔt with respect to ΔVΔt is 0V0V0+ΔVΔtt1+GFRKΔVΔt.

To calculate the derivative of the exponential, let y=V0V0+ΔVΔtt1+GFRKΔVΔt and use logarithms.

lny=lnV0V0+ΔVΔtt1+GFRKΔVΔt=1+GFRKΔVΔt·lnV0V0+ΔVΔtt.

Differentiate with the product rule:

1yy=GFRKΔVΔt2·lnV0V0+ΔVΔtt+1+GFRKΔVΔt·V0+ΔVΔttV0·V0·tV0+ΔVΔtt2.
1yy=GFRKΔVΔt2·lnV0V0+ΔVΔtt1+GFRKΔVΔt·tV0+ΔVΔtt.
y=V0V0+ΔVΔtt1+GFRKΔVΔt·GFRKΔVΔt2·lnV0V0+ΔVΔtt+1+GFRKΔVΔt·tV0+ΔVΔtt.

Thus,

1V0V0+ΔVΔtt1+GFRKΔVΔt=V0V0+ΔVΔtt1+GFRKΔVΔt·GFRKΔVΔt2·lnV0V0+ΔVΔtt+1+GFRKΔVΔt·tV0+ΔVΔtt.

Next, find the derivative of GenGFRK+ΔVΔtCr0 with respect to ΔVΔt:

GenGFRK+ΔVΔtCr0=GenGFRK+ΔVΔt2.

Using the two intermediate derivatives for the product rule applied to Equation (2) of the main text, we find that CrtΔVΔt is:

CrtΔVΔt=V0V0+ΔVΔtt1+GFRKΔVΔt·GFRKΔVΔt2·lnV0V0+ΔVΔtt+1+GFRKΔVΔt·tV0+ΔVΔtt×GenGFRK+ΔVΔtCr0+1V0V0+ΔVΔtt1+GFRKΔVΔt·GenGFRK+ΔVΔt2.

Chen, S., & Chiaramonte, R. (2021). In creatinine kinetics, the glomerular filtration rate always moves the serum creatinine in the opposite direction. Physiological Reports, 9, e14957. 10.14814/phy2.14957

REFERENCES

  1. Bairy, M. (2020). Using kinetic eGFR for drug dosing in AKI: Concordance between kinetic eGFR, Cockroft‐Gault estimated creatinine clearance, and MDRD eGFR for drug dosing categories in a pilot study cohort. Nephron, 144, 299–303. 10.1159/000507260 [DOI] [PubMed] [Google Scholar]
  2. Bairy, M., See, F. H. W., & Lim, R. S. (2018). Using the kinetic estimating glomerular filtration rate equation for estimating glomerular filtration rate and detecting acute kidney injury: A pilot study. Nephron, 140, 231–239. 10.1159/000492439 [DOI] [PubMed] [Google Scholar]
  3. Bjornsson, T. D. (1979). Use of serum creatinine concentrations to determine renal function. Clinical Pharmacokinetics, 4, 200–222. [DOI] [PubMed] [Google Scholar]
  4. Chen, S. (2013). Retooling the creatinine clearance equation to estimate kinetic GFR when the plasma creatinine is changing acutely. Journal of the American Society of Nephrology, 24, 877–888. 10.1681/ASN.2012070653 [DOI] [PubMed] [Google Scholar]
  5. Chen, S. (2018a). Kinetic glomerular filtration rate equation can accommodate a changing body volume: Derivation and usage of the formula. Mathematical Biosciences, 306, 97–106. 10.1016/j.mbs.2018.05.010 [DOI] [PubMed] [Google Scholar]
  6. Chen, S. (2018b). Kinetic glomerular filtration rate in routine clinical practice‐applications and possibilities. Advances in Chronic Kidney Disease, 25, 105–114. 10.1053/j.ackd.2017.10.013 [DOI] [PubMed] [Google Scholar]
  7. Chen, S., & Chiaramonte, R. (2019). Estimating creatinine clearance in the nonsteady state: The determination and role of the true average creatinine concentration. Kidney Medicine, 1, 207–216. 10.1016/j.xkme.2019.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chiou, W. L., & Hsu, F. H. (1975). A new simple and rapid method to monitor the renal function based on pharmacokinetic consideration of endogeneous creatinine. Research Communications in Chemical Pathology and Pharmacology, 10, 315–330. [PubMed] [Google Scholar]
  9. Chow, M. S. (1985). A method for determining the pharmacokinetics of endogenous creatinine without exogenous creatinine administration. Biopharmaceutics & Drug Disposition, 6, 201–208. 10.1002/bdd.2510060210 [DOI] [PubMed] [Google Scholar]
  10. Dash, J., Verissimo, T., Faivre, A., Berchtold, L., Berney, T., Pugin, J., de Seigneux, S., & Legouis, D. (2020). Kinetic GFR outperforms CKD‐EPI for slow graft function prediction in the immediate postoperative period following kidney transplantation. Journal of Clinical Medicine, 9, 1–9. 10.3390/jcm9124003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dewitte, A., Joannes‐Boyau, O., Sidobre, C., Fleureau, C., Bats, M. L., Derache, P., Leuillet, S., Ripoche, J., Combe, C., & Ouattara, A. (2015). Kinetic eGFR and Novel AKI biomarkers to predict renal recovery. Clinical Journal of the American Society of Nephrology, 10, 1900–1910. 10.2215/CJN.12651214 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Doi, K., Yuen, P. S., Eisner, C., Hu, X., Leelahavanichkul, A., Schnermann, J., & Star, R. A. (2009). Reduced production of creatinine limits its use as marker of kidney injury in sepsis. Journal of the American Society of Nephrology, 20, 1217–1221. 10.1681/ASN.2008060617 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Edwards, K. D. (1959). Creatinine space as a measure of total body water in anuric subjects, estimated after single injection and haemodialysis. Clinical Science, 18, 455–464. [PubMed] [Google Scholar]
  14. Endre, Z. H., Pianta, T. J., & Pickering, J. W. (2016). Timely diagnosis of acute kidney injury using kinetic eGFR and the creatinine excretion to production ratio, E/eG ‐ creatinine can be useful! Nephron, 132, 312–316. 10.1159/000444456 [DOI] [PubMed] [Google Scholar]
  15. Jelliffe, R. (2002). Estimation of creatinine clearance in patients with unstable renal function, without a urine specimen. American Journal of Nephrology, 22, 320–324. 10.1159/000065221 [DOI] [PubMed] [Google Scholar]
  16. Jones, J. D., & Burnett, P. C. (1974). Creatinine metabolism in humans with decreased renal function: Creatinine deficit. Clinical Chemistry, 20, 1204–1212. 10.1093/clinchem/20.9.1204 [DOI] [PubMed] [Google Scholar]
  17. Khayat, M. I., Deeth, J. M., & Sosnov, J. A. (2019). A bedside clinical tool using creatinine kinetics to predict worsening renal injury and early recovery. Clinical Kidney Journal, 12, 248–252. 10.1093/ckj/sfy069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kwong, Y. D., Chen, S., Bouajram, R., Li, F., Matthay, M. A., Mehta, K. M., Glidden, D. V., & Liu, K. D. (2019). The value of kinetic glomerular filtration rate estimation on medication dosing in acute kidney injury. PLoS One, 14, e0225601. 10.1371/journal.pone.0225601 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Latha, A. V., Rameshkumar, R., Bhowmick, R., & Rehman, T. (2020). Kinetic estimated glomerular filtration rate and severity of acute kidney injury in critically Ill children. Indian Journal of Pediatrics, 87, 995–1000. 10.1007/s12098-020-03314-y [DOI] [PubMed] [Google Scholar]
  20. Mellas, J. (2016). The description of a method for accurately estimating creatinine clearance in acute kidney injury. Mathematical Biosciences, 275, 107–114. 10.1016/j.mbs.2016.02.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Moran, S. M., & Myers, B. D. (1985). Course of acute renal failure studied by a model of creatinine kinetics. Kidney International, 27, 928–937. 10.1038/ki.1985.101 [DOI] [PubMed] [Google Scholar]
  22. O'Sullivan, E. D., & Doyle, A. (2017). The clinical utility of kinetic glomerular filtration rate. Clinical Kidney Journal, 10, 202–208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pianta, T. J., Endre, Z. H., Pickering, J. W., Buckley, N. A., & Peake, P. W. (2015). Kinetic estimation of GFR improves prediction of dialysis and recovery after kidney transplantation. PLoS One, 10, e0125669. 10.1371/journal.pone.0125669 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pickering, J. W., Ralib, A. M., & Endre, Z. H. (2013). Combining creatinine and volume kinetics identifies missed cases of acute kidney injury following cardiac arrest. Critical Care, 17, R7. 10.1186/cc11931 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Prowle, J. R., Kolic, I., Purdell‐Lewis, J., Taylor, R., Pearse, R. M., & Kirwan, C. J. (2014). Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI. Clinical Journal of the American Society of Nephrology, 9, 1015–1023. 10.2215/CJN.11141113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yashiro, M., Ochiai, M., Fujisawa, N., Kadoya, Y., & Kamata, T. (2012). Evaluation of estimated creatinine clearance before steady state in acute kidney injury by creatinine kinetics. Clinical and Experimental Nephrology, 16, 570–579. 10.1007/s10157-012-0602-x [DOI] [PubMed] [Google Scholar]
  27. Yoshida, T., Matsuura, R., Komaru, Y., Miyamoto, Y., Yoshimoto, K., Hamasaki, Y., Noiri, E., Morimura, N., Nangaku, M., & Doi, K. (2019). Kinetic estimated glomerular filtration rate as a predictor of successful continuous renal replacement therapy discontinuation. Nephrology (Carlton), 24, 287–293. 10.1111/nep.13396 [DOI] [PubMed] [Google Scholar]

Articles from Physiological Reports are provided here courtesy of Wiley

RESOURCES